Document Detail

More than satiety: central serotonin signaling and glucose homeostasis.
MedLine Citation:
PMID:  17983579     Owner:  NLM     Status:  MEDLINE    
Serotonergic agents have been used in the past for reduction of appetite and body weight. As reported by Zhou et al. (2007) in this issue of Cell Metabolism, they also have unexpected effects on peripheral glucose homeostasis independent of food intake and body weight.
Pavlos Pissios; Eleftheria Maratos-Flier
Related Documents :
11392389 - Tarsal asymmetry, nutritional condition, and survival in water boatmen (callicorixa vul...
17655879 - Nicotine's attenuation of body weight involves the perifornical hypothalamus.
6131779 - Seasonally-related physiological and behavioural changes in captive richardson's ground...
23130689 - Compensatory growth in juvenile roach rutilus caspicus: effect of starvation and re-fee...
463809 - A two-reservoir energy model of the human body.
18047229 - Seasonal variation in pigeon body weight and delayed matching-to-sample performance.
9294639 - Transfer of tools and food between groups of tufted capuchins (cebus apella).
3411949 - Do nutritional alterations contribute to adriamycin-induced impaired wound healing?
19425959 - Foraging rules for nectar: food choices by painted ladies.
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  Cell metabolism     Volume:  6     ISSN:  1550-4131     ISO Abbreviation:  Cell Metab.     Publication Date:  2007 Nov 
Date Detail:
Created Date:  2007-11-06     Completed Date:  2008-02-26     Revised Date:  2014-09-14    
Medline Journal Info:
Nlm Unique ID:  101233170     Medline TA:  Cell Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  345-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Glucose / metabolism*
Homeostasis / drug effects*
Models, Biological
Serotonin 5-HT2 Receptor Agonists
Serotonin Receptor Agonists / pharmacology*
Signal Transduction / drug effects
Grant Support
P01 DK056116/DK/NIDDK NIH HHS; P01 DK056116-010002/DK/NIDDK NIH HHS; P01 DK056116-020002/DK/NIDDK NIH HHS; P01 DK056116-030002/DK/NIDDK NIH HHS; P01 DK056116-040002/DK/NIDDK NIH HHS; P01 DK056116-050002/DK/NIDDK NIH HHS; P01 DK056116-06A10002/DK/NIDDK NIH HHS; P01 DK056116-06A19002/DK/NIDDK NIH HHS; P01 DK056116-070002/DK/NIDDK NIH HHS; P01 DK056116-079002/DK/NIDDK NIH HHS; P01 DK056116-080002/DK/NIDDK NIH HHS; P01 DK056116-089002/DK/NIDDK NIH HHS; P01 DK056116-090002/DK/NIDDK NIH HHS; P01 DK056116-099002/DK/NIDDK NIH HHS; R01 DK056113/DK/NIDDK NIH HHS; R01 DK056113-05/DK/NIDDK NIH HHS; R01 DK069983/DK/NIDDK NIH HHS; R01 DK069983-01A1/DK/NIDDK NIH HHS; R01 DK069983-02/DK/NIDDK NIH HHS; R01 DK069983-03/DK/NIDDK NIH HHS
Reg. No./Substance:
0/Serotonin 5-HT2 Receptor Agonists; 0/Serotonin Receptor Agonists; IY9XDZ35W2/Glucose
Comment On:
Cell Metab. 2007 Nov;6(5):398-405   [PMID:  17983585 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  DisSIRTing on LXR and cholesterol metabolism.
Next Document:  Metabolomics.